BNTC (Benitec Biopharma) Net Margin %: 0.00% (As of Mar. 2026)


BNTC Benitec Biopharma Inc BNTC
34 GF Score
Price $13.07
View Full Analysis

What is Benitec Biopharma Net Margin %?

Benitec Biopharma BNTC -4.49% 34 Net Margin % is 0.00% as of Mar. 2026. GuruFocus rates BNTC with a GF Score™ of 34/100. Among 947 Biotechnology companies, Benitec Biopharma ranks worse than 105596.52% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Benitec Biopharma's Net Income for the three months ended in Mar. 2026 was $-11.94 Mil. Benitec Biopharma's Revenue for the three months ended in Mar. 2026 was $0.00 Mil. Therefore, Benitec Biopharma's net margin for the quarter that ended in Mar. 2026 was 0.00%.

The historical rank and industry rank for Benitec Biopharma's Net Margin % or its related term are showing as below:


BNTC's Net Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -89.33
* Ranked among companies with meaningful Net Margin % only.

Benitec Biopharma  (NAS:BNTC) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Benitec Biopharma Net Margin % Related Terms

Benitec Biopharma Net Margin % Historical Data

* Premium members only.

The historical data trend for Benitec Biopharma's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Benitec Biopharma Net Margin % Chart

Benitec Biopharma Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -23,528.81 -24,942.47 -26,082.67 0.00 0.00

Benitec Biopharma Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BNTC vs OABI, FBRX, LXEO: Net Margin % Comparison

For the Biotechnology subindustry, Benitec Biopharma's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Benitec Biopharma Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Benitec Biopharma's Net Margin % distribution charts can be found below:

* The bar in red indicates where Benitec Biopharma's Net Margin % falls into.


BNTC
34GF Score
Benitec Biopharma Inc BNTC
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Benitec Biopharma Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Benitec Biopharma's Net Margin for the fiscal year that ended in Jun. 2025 is calculated as

Net Margin=Net Income (A: Jun. 2025 )/Revenue (A: Jun. 2025 )
=-37.917/0
= %

Benitec Biopharma's Net Margin for the quarter that ended in Mar. 2026 is calculated as

Net Margin=Net Income (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-11.935/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 0.00% mean?
Benitec Biopharma (BNTC) has a Net Margin % of 0.00% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Benitec Biopharma and its competitors. According to the industry distribution chart, Benitec Biopharma ranks #999999 out of 947 companies in the Biotechnology industry.
Is Benitec Biopharma's Net Margin % too high?
Benitec Biopharma's current Net Margin % is 0.00%. Based on the distribution chart, Benitec Biopharma ranks #999999 out of 947 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Benitec Biopharma has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Benitec Biopharma's Net Margin % compare to OABI and FBRX?
According to the Biotechnology industry distribution chart, Benitec Biopharma ranks #999999 out of 947 companies for Net Margin %. This places Benitec Biopharma in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Benitec Biopharma and its competitors. Benitec Biopharma's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Benitec Biopharma stock overvalued right now?
Benitec Biopharma (BNTC) has a current Net Margin % of 0.00%. The current Net Margin % is 0.00%. Benitec Biopharma's overall GF Score™ is 34/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Benitec Biopharma (BNTC), the current Net Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Benitec Biopharma Business Description

Address 3940 Trust Way, Hayward, CA, USA, 94545
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.
34GF Score

Get the complete analysis for BNTC

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$13.07
Price